1 ΒΙΟΓΡΑΦΙΚΟ ΣΗΜΕΙΩΜΑ ΠΡΟΣΩΠΙΚΑ ΣΤΟΙΧΕΙΑ Ονοματεπώνυμο Κυριακή Θερμού (K. Thermos) Ημερομηνία Γέννησης 17 Δεκεμβρίου 1954 Τόπος Γέννησης Καρυά-Λευκάδος Διεύθυνση Οικίας Βούτες, Ηράκλειο Τηλέφωνο Οικίας 2810-721 363 Διεύθυνση Εργασίας Πανεπιστήμιο Κρήτης Ιατρικό Τμήμα Τομέας Βασικών Επιστημών Ηράκλειο, Κρήτης Τηλέφωνο 2810-394533 Φαξ 2810-394530 Ηλεκτρονική διεύθυνση [email protected]ΣΠΟΥΔΕΣ Πρωτοβάθμιες 1960-1966 Δημοτικό Σχολείο Καρυάς, Λευκάδος Δευτεροβάθμιες 1966-1972 Public Junior & Walton High School Bronx, New York Πανεπιστημιακή Εκπαίδευση 1972-1973 Πανεπιστήμιο της Καλιφόρνιας στο Los Angeles (UCLA) (major: Χημεία) 1973-1976 Πανεπιστήμιο Πάτρας, Τμήμα Χημείας Οκτ. 1976 Πτυχίο Χημείας (Λίαν Καλώς), Πανεπιστήμιο Πάτρας Μεταπτυχιακή Εκπαίδευση 1977 -1979 Μεταπτυχιακό Πρόγραμμα του Χημικού Τμήματος του Πανεπιστημίου της Νέας Υόρκης (New York University, N.Y.) 1979 Απονομή Μεταπτυχιακού Διπλώματος (Master of Science)
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
«Λειτουργική χαρτογράφηση των υποδοχέων σωματοστατίνης στα βασικά γάγγλια μέσω της
μελέτης των αλληλεπιδράσεων του πεπτιδίου με άλλα νευροδιαβιβαστικά συστήματα:
προεκτάσεις του ρόλου της σωματοστατίνης στην παθοφυσιολογία νόσων του ΚΝΣ»,
Θέση σήμερα: Ερευνήτρια, Τμήμα Ιατρικής, Πανεπιστημίου Πατρών.
6. Νίκη Μαστροδήμου, 2000-2010
«Μελέτη του Ρόλου της Σωματοστατίνης και Κορτιστατίνης στον Αμφιβληστροειδή και
στην Ισχαιμική Αμφιβληστροπάθεια», Διδακτορική Διατριβή, Θέση σήμερα: ΕΔΙΠ,
Εργαστήριο Φαρμακολογίας, Ιατρικό Τμήμα, Π.Κ..
7. Θέκλα Παπαδάκη, 2010
«Μελέτη του ρόλου της σωματοστατίνης στο μελάχρουν επιθήλιο του αμφιβληστροειδούς»,
Διδακτορική Διατριβή, Θέση σήμερα: Οφθαλμίατρος
8. Φωτεινή Κιαγιαδάκη, 2009
«Ιn vivo μελέτη της προστατευτικής δράσης της σωματοστατίνης στην αμφιβληστροειδική
ισχαιμία» Διδακτορική Διατριβή. Θέση σήμερα: Ερευνήτρια σε Ιδιωτικό Διαγνωστικό
Κέντρο
9. Δέσποινα Κοκονά, 2015
«Μελέτη της νευροπροστατευτικής δράσης της κανναβινοειδών στην αμφιβληστροειδική
ισχαιμία», Research Assistant, Department of Ophthalmology, University of Bern, SW
10. Ruth Iban Arias, 2018
«Μελέτη Νέων Θεραπευτικών Στόχων για την αντιμετώπιση της Διαβητικής Αμφιβληστροει-δοπάθειας: Νευροστεροειδή/Μικρονευροτροφίνες»,
Μεταδιδάκτορας, Icahn School of Medicine at Mount Sinai, Departments of Psychiatry
and Neuroscience (Lab: Prof. N. Robakis)
11.Σοφία Παπαδογκωνάκη, 2016-
«Μελέτη της επίδρασης της χρόνια χορήγησης ενδογενών και συνθετικών κανναβινοειδών στη λειτουργία του κανναβινοειδικού υποδοχέα τύπου-1 (CB1) στον υγιή αμφιβληστροειδή και σε πειραματικό μοντέλο αμφιβληστροειδοπάθεια»
12. Σταυρούλα Διονυσοπούλου, 26/03/19-
"Μελέτη του ρόλου των αναστολέων των NADPH οξειδασών σε πειραματικά, ζωικά μοντέλα
αμφιβληστροειδοπαθειών"
13. Δημήτρης Σπυριδάκος, 26/03/19-
"Το σύστημα των ενδογενών κανναβινοειδών ως θεραπευτικός στόχος για την αντιμετώπιση
of canine striatal receptor sites by [3H]chlorpromazine, Proc. Soc. for Neurosci. 9:1116, 1983. 2. Schuster, D.I., Murphy, R.B., Thermos, K., Libes, R.B., Photolabeling of neurotransmitter
receptor sites in the brain, Am. Chem. Soc. Meeting, Philadelphia, PA, USA, 1984.
3. Thermos, K. and Weiss, B., Irreversible interaction of fluphenazine (F) and fluphenazine-N-
mustard (FNM) with [3H]spiroperidol binding sites in vivo and in vitro, Fed. Proc., 44:1828, 1985. 4. Katerinopoulos, H., Thermos, K. and Schuster, D.I., Synthesis and in vitro binding studies
of exo-2 {N,n-propylamino] and exo 2-[N,N di-n-propylamino]6,7-dihydroxybenzo-norbornene and
exo-2-amino-6,7-dihydroxy-benzobicyclo-[2.2.2]-octene rigid dopamine analogues, presented at the Second Cyprus Conference on New Methods in Drug Research, Limasso, Cyprus, 1985.
5. Thermos, K., Winkler, J.D., Weiss, B., Effects of an irreversible dopaminergic ligand,
fluphenazine-N-mustard, on dopaminergic behavior in supersensitive mice. Proc. Soc. for Neurosci. 11:923, 1985.
26
6. Weiss, B., Goodale, D.B., Thermos, K., Winkler, J.D., Modulation of dopaminergic receptors, Presented at the Fourth Capo Boi Conference on Neuroscience, Sardinia, Italy, 1985.
7. Thermos, K., Prozialeck, W., Weiss, B., Isolation of sites in mouse striatum irreversibly
labeled with fluphenazine-N-mustard and apomorphine, Proc.Soc. for Neurosci. 12: 989, 1986. 8. Winkler, J.D., Thermos, K., Weiss, B., Differential effects of the irreversible dopaminergic
antagonist, fluphenazine-N-mustard on D1 and D2 dopaminergic behavior and radioligand binding in
supersensitive mice. Presented at the 15th Congress of the Collegium International Neuro-
Psychopharmacol., San Juan, Puerto Rico, 1986. 9. Thermos, K. and Reisine, T., Molecular characteristics of somatostatin receptors in pituitary
cells. Proc. Soc. for Neurosci., 13:1522, 1987.
10. Reisine, T., Margolis, N., and Thermos, K., Molecular mechanisms controlling POMC gene expression and ACTH release. Psychopharmacology 96 (Suppl): 60, 1988.
11. Thermos, K., He, H-T., Margolis, N., Reisine, T., Biochemical properties of brain
somatostatin receptors. Proc. Soc. for Neurosci., 14:14,1988. 12. Margolis, N., Thermos, K., Reisine, T., Molecular Mechanisms of POMC gene expression,
Proc. Soc. of Neurosci. 14: 1285, 1988.
13. Reisine, T., He, H-T., Rens-Domiano, S., Reynar, K., Borislow, S. and Thermos, K.
Purification and structural characterization of somatostatin receptors. Intl. Symp. on Somatostatin, Montreal, Canada, 1989.
14. Thermos, K. and Reisine, T. Biochemical characteristics of somatostatin receptors in brain.
Abstracts of the 12th Annual Meeting of the European Neuroscience Assoc., p. 195, Turin, 1989. 15. Liapakis, G. and Thermos, K. Characterization of [125I]Tyr11-Somatostatin binding sites in
the rabbit retina. 14th Annual Meeting of the European Neurosci. Assoc., Cambridge,1991.
16. Radke, J., Spyraki, C., and Thermos, K. Measurement of extracellular somatostatin using in
vivo microdialysis. 14th Annual Meeting of the European Neurosci. Assoc., Cambridge, 1991. 17. Kouvarakis, A., Thermos, K. and Katerinopoulos, H.E. Synthesis and dopaminergic activity
of 2-amino-1,4-epoxy-1,2,3,4-tetrahydronapthalenes. Abstracts of the Annual American Chemical
Society Meeting, New York, N.Y. 1991. 18. Radke, J., Spyraki, C. and Thermos, K. Study of extracellular levels of somatostatin in the
rat brain using in vivo intracerebral microdialysis: Effect of amphetamine. 5th International
Conference on in vivo methods, The Netherlands, 1991. 19. Politou, E., Liapakis, G. and Thermos, K. Photolabeling of somatostatin receptors in retina.
Biochem. Biophys. Balkan Meeting, Thessaloniki, 1992.
20. Gheorvasaki, E., Thermos, K., Liapakis, G., Spyraki, C. Effect of acute and chronic
treatment of desipramine on somatostatin receptors in brain. Biochem. Biophys. Balkan Meeting, Thessaloniki, 1992.
21. Gheorvasaki, E., Thermos, K., Liapakis, G. and Spyraki, C. Effects of acute and chronic
desipramine treatment on somatostatin receptors. EBPS Meeting, Cambridge, England, 1992 22. Liapakis, G. and Thermos, K. Biochemical and pharmacological characterization of
somatostatin receptors from rabbit retina. 13th European Winter Conference on Brain Research, La
Plagne, France, 1993. 23. Liapakis, G. and Thermos, K. Solubilization of somatostatin receptors from rabbit retina.
First International Neuropsychopharmacology Meeting, Rhodos, 1993.
24. Thermos, K., Radke, J. and Spyraki, C. Dopamine-Somatostatin interactions in the caudate
nucleus. Meeting of European Association of Neuroscience, Madrid, 1993. 25. Radke, J., Spyraki, C. and Thermos, K. Regulation of somatostatin release in the basal
ganglia. Meeting of the American Neuroscience Association, Washington, D.C., 1993.
26. Radke, J., Spyraki, C. and Thermos, K. Effect of excitatory amino acids on the release of somatostatin in the rat striatum: in vivo microdialysis studies. 17th Annual Meeting of the European
Neuroscience Association, Vienna, Austria, 1994.
27
27. Radke, J., Spyraki, C. and Thermos, K. Glutamate-Somatostatin Interactions in the Rat Striatum: an in vivo microdialysis study., Meeting of the American Neuroscience Association, Miami,
Florida, USA, 1994.
28. Kouroumalis, E.A., Skordilis, P., Liapakis, G., Thermos, K., and Manousos, O. N. Treatment of hepatocellular carcinoma with somatostatin. Annual Meeting of the British Society of
Gastroenterology , London, England 1994.
29. Katerinopoulos, H.E., Tagmatarhis, N., Zaponakis, G. and K. Thermos. Conformationally
flexible analogs of Abbot-68930 studies on dopaminergic and ·-adrenergic activity. Am. Chem.Soc. Meeting, Washington, USA, 1994.
30. Vasilaki, A., Hatzilaris, E., Liapakis, G., Georgoussi, Z. and Thermos, K. Somatostatin
receptor subtypes (SSTR2) in the rabbit retina. Meeting of the American Society for Neuroscience, November, Washington, D.C., 1996.
31. Hatzoglou, A., Ouafik, L’H., Bakogeorgiou, E., Thermos, K. and Castanas, E. Morphine
cross-reacts with somatostatin receptors in the T47D human breast cancer cell line, and decreases cell proliferation. 21st Meeting of the Int. Assoc. for Breast Cancer Res, Paris, France, 1996.
32. Katerinopoulos, H.E., Tagmatarhis, N., Thermos, K. N-Iodopropenyl-octahydrobenzo[f]-
and-[g]Quinoline analogs with adrenergic and dopaminergic activity. ACS Meeting, Las Vegas, USA
1997. 33. Hatzoglou, A., Bakogeorgiou, E., Kampa, M., Ouafik, L’H., Thermos, K. and Castanas, E.
Interaction of opioid alkaloids and peptides with opioid receptors. 8th Meeting of of the European
Neuroendocrine Association, Marseille, 1997. 34. Hatzoglou, A., Bakogeorgiou, E., Kampa, M., Ouafik, L’H., Thermos, K. and Castanas, E.
Interactions of opioid alkaloids and peptides with somatostatin receptors. Annales d' Endocrinologie,
58: 1S41 (P32), 1997.
35. Pallis, E.G., Thermos, K. and Spyraki, C. Somatostatin-induced dopamine release in rat nucleus accumbens after antidepressant chronic treatment: an in vivo microdialysis study. 3rd ECNP
Meeting, Athens, 1998.
36. Papadaki, T., Tsilibaris, Μ.,. Koutentaki,M., Samonakis, D., Kouroumalis, E., Thermos, K., Pallikaris, I. The role of somatostatin in the treatment of subretinal neovascularization (SRNV): a
37. Vasilaki, A., Giakoumaki, S., Mastrodimou, N., Gardette, R.,Epelbaum, J. and Thermos, K. NADPH-diaphorase colocalizes with somatostatin receptor subtypes sst2A and sst2B in the rat and
rabbit retina. Forum of European Neuroscience, Brighton, June 2000
38. Pallis, E., Thermos, K, Spyraki, C. Dopamine (DA)-somatostatin (SOM) interactions after
antidepressant chronic treatment. Forum of European Neuroscience, Brighton, June 2000 39. Thermos, K., Pallis, E. and Spyraki, C. Somatostatin and its receptors: Molecular biology to
therapeutics. 6th World Hellenic Biomedical Congress, Athens, October 2000.
40. Vasilaki, A., Grigoryan, E.N., Mastrodimou, N. and Thermos K. Somatostatin receptor (sst3) immunoreactivity in the eye of the adult newt. Am Soc Neurosci., New Orleans, November 2000.
41. Papadaki T, Tsilimbaris M, Thermos K, Markianou M, Pallikaris I. The role of lanreotide in
the treatment of choroidal neovascularization secondary to age-related macular degeneration: A pilot clinical trial. Aegean Retina VII, July 6-8, 2001 Crete-Greece.
42. Vasilaki, A., Notas, G., Schulz, S., Kouroumalis, E., Thermos, K. Mapping of somatostatin
receptors in the rat retina and colocalization with NADPH-Diaphorase. Effect of somatostatin on
nitric oxide production. Soc for Neurosci., San Diego, Nov 2001. 43. Pallis, E., Vasilaki, A., Spyraki, C., Thermos, K. Effect of citalopram treatment on
somatostatin release and [125I]Tyr11 somatostatin binding in the brain. FENS Forum, Paris, France,
2002. 44. Notas, G., Kampa, M., Xidakis, C., Valatas, V., Vasilaki, A., Thermos, K., Kolios, G.,
Castanas, E., Kouroumalis, E. Octreotide and opioids inhibit the proliferation of human hepatocellular
carcinoma (HCC) cell line GEPG2 with concurrent increase of nitric oxide (NO) production.
28
"Somatostatin receptor physiology and targets for somatostatin analogue therapy" - A Young Investigator Meeting. Barcelona, 2002.
45. Thermos, Κ., Vasilaki, A., Papasava,D., Kocharian, A., Schulz, S., Hoyer, D.,
Meyerhof, W. The somatostatin receptor (sst1) is an autoreceptor in the nucleus accumbens. IBRO
Meeting, Prague, 2003
46. Mastrodimou, N., Lambrou, G., Thermos, K. Effect of somatostatin, cortistatin and sst2
agonists on chemically Induced Ischemia In rat retina, IBRO Meeting, Prague, 2003
47. Notas, G., Kampa, M., Vasilaki, A., Xidakis, C., Valatas, V., Thermos, K., Kolios, G., Castanas, E., Kouroumalis, E. Octreotide and opioids reduce the rate of proliferation of human
hepatocellular carcinoma (HCC) cell line HEPG2, with parallel increase of nitric oxide (NO)
production. J. Hepatology 38 (suppl 2), p.103, 2003. 48. Notas, G., Kolios, G., Mastrodimou, N. , Kampa, M. , Xidakis, C. , Castanas, E. , Thermos,
K., Kouroumalis, E. Cortistatin production by HepG2 hepatocellular carcinoma cell line and
distribution of somatostatin receptors. Gut 2003; 52 (Suppl VI) A72. 49. Thermos, K., Kastellakis, A., Papasava, D., Antoniou, K. Somatostatin receptors in the
Kouroumalis, E. Proinflammatory cytokines modulate the expression and distribution of somatostatin receptors on HEPG2 hepatocellular carcinoma cells. VEGW, Prague, 2004.
51. Spyraki, C., and Thermos, K. The evolution of antidepressant strategies. A dual Congress:
“Psychiatry and the Neurosciences”. 5th International Congress of Neuropsychiatry and 1st Mediterranean Regional Congress of the World Federation Societies of Biological Psychiatry. Athens,
Oct 2004.
52. Kolios,G., Batistakis, A., Manousou, P., Drygiannakis, I., Notas, G., Thermos, K.,
Kouroumalis, E. Cannabinoid receptor expression and regulation in colonic epithelial cell lines. 13th United European Gastroenterology Week "UEGW 2005", Copenhagen, Denmark, 15-19 October
2005.
53. Κouvidi, Ε., Mastrodimou, N., Kiagiadaki, F., Thermos, K. SRIF modulates dopamine and cGMP levels in rat retina. 35th Annual Meeting of the Society for Neuroscience, Washington, D.C.,
Nov. 2005.
54. Thermos, K., Pallis, E., Vasilaki, A., Hoyer, D., Spyraki, C. Antidepressant strategies and the putative role of somatostatin. 7th International Meeting of Medicinal Chemistry, Patras, 8-11 March,
2006 (invited speaker)
55. Marazioti, A., Spyraki, C., Thermos, K. Activation of somatostatin receptors in the globus
pallidus influences rat locomotor activity and increases cFOS expression in brain areas implicated in motor control. Meeting of the Federation of the European Neuroscience Societies (FENS), Vienna,
2006.
56. Panagis, G., Antoniou, K., Papazoglou, M., Mastrodimou, N., Polissidou, A., Vlachou, S., Nahmias, E. V., Kondylis, M.P., Thermos, K., Papahatjis, D., Daifoti-Papadopoulou, Z., Spyraki,
C. Pharmacological profile of DPG4. A new ligand for CB1 and CB2 cannabinoid receptors.
Meeting of the Federation of the European Neuroscience Societies (FENS), Vienna, 2006 57. Thermos, K., Papazoglou, M., Antoniou, K., Mastrodimou, N., Panagis, G., Vlachou, S.,
Renieri, E., Nahmias, V. , Menissiou, A., Gianni, M., Kondylis, M.P. , Papahatzis, D., Spyraki, C.
Pharmacological characterization of novel ligands for CB1 and CB2 cannabinoid receptors. The 15 th
World Congress of Pharmacology, IUPHAR, Beijing, 2006. 58. Marazioti, A., Spyraki, C., Thermos K. Somatostatin (SRIF) infused in the globus pallidus
increases locomotor activity and cFos expression in rat brain areas implicated in motor control. The
15th World Congress of Pharmacology, IUPHAR, Beijing, 2006. 59. Pallis, E., Vasilaki, A., Fehlmann, D., Hoyer, D., Spyraki, C., Thermos, K. Acute and chronic
administration of citalopram influences somatostatin levels and receptor expression in brain. 36th
Annual Meeting of the Society for Neuroscience, Atlanta, October 2006.
29
60. Thermos, K. , Mastrodimou, N. , Papazoglou, M., Antoniou, K. , Panagis, G., Vlachou, S., Nahmias, V., Menissiou, A., Gianni, M., Papahatjis, D. , Kondylis, M., Spyraki, C.
Pharmacological and behavioral characterization of novel ligands for CB1 and CB2 cannabinoid
receptors. 36th Annual Meeting of the Society for Neuroscience, Atlanta, October 2006. 61. Mastrodimou N. and Thermos K. Effect of SIN-1 and 8-Br-cGMP in chemical ischemia in rat
retina. 20th Meeting of the Hellenic Society for Neuroscience, Heraklion, p. 83-85. 2006.
62. Antoniou K., Panagis G., Thermos K., Papazoglou M., Mastrodimou N., Polissidis A., Vlachou
S., Nahmias V., Menissiou A., Gianni M., Kondylis M. P., Papahatjis D., Daifoti-Papadopoulou Z. and Spyraki C. Pharmacological profile of DPG-4 a new ligand for CB1 and CB2 cannabinoid
receptors. 16th Annual Symposium On The Cannabinoids, Tihany / Hungary, June 24-28, 2006.
63. Thermos, K., Papazoglou, M., Antoniou, K., Mastrodimou, N., Panagis, G., Vlachou, S., Renieri, E., Nahmias, V., Menisiou, A., Gianni, M., Kondylis, M.P., `Daifoti-Papadopoulou, Z., Papahatjis, D.,
Spyraki, C. Pharmacological characterization of novel ligands for CB1 and CB2 Cannabinoid
Receptors. 4th Panhellenic Congress of Pharmacology, Patras. Review of Clinical Pharmacology and Pharmacokinetics, International Edition, 20(2), 335, 2006.
64. Panagis, G., Antoniou, K., Thermos, K., Papazoglou, M., Mastrodimou, N., Polissidis, A.,
Vlachou, S., Nahmias, V., Kondylis, M.P., Papahatjis, D., Daifoti-Papadopoulou, Z., Spyraki, C.
Pharmacological profile of DPG-4, a new ligand for CB1 and CB2 cannabinoid Receptors. 4th Panhellenic Congress of Pharmacology, Patras. Review of Clinical Pharmacology and
Pharmacokinetics, International Edition 20(2), 263, 2006.
65. Mastrodimou N. and Thermos K. Study of the neuroprotective effect of NO donors and 8-Br-cGMP in retinal ischemia and as players in somatostatin’s actions. 7th IBRO World Congress of
Neuroscience, Melbourne, Australia, 2007.
66. Pallis E., Antoniou K., Papadopoulou-Daifoti Z., Thermos, K., Spyraki C. Meeting of European
67. Kiagiadaki F., Thermos K. Somatostatin and sst2 analogs protect the retina from AMPA-induced
excitotoxicity. FEBS Annual Meeting, Athens, June 2008 68. Kiagiadaki F., Thermos K. Intravitreal Administration of Somatostatin and sst2 Analogs Protect
the Retina from AMPA-Induced Excitotoxicity. 6th Forum of European Neuroscience Societies
(FENS), Geneva, July 2008. 69. Mastrodimou, N., Kiagiadaki, F., Thermos, K. Somatostatin analogues as therapeutics in retinal
71. Thermos K., Giannogonas P., Mastrodimou N., Charalampopoulos I. & Gravanis A.
Neurosteroids Protect the Retina in a Rat Model of Chemical Ischemia. 7th Forum of European Neuroscience, Amsterdam / The Netherlands, July 3-7, 2010.
72. Georgiou, P.-D., Kiagiadaki, F., Thermos, K. Cannabinoids protect the retinal from chemical
ischemia via CB1 activation. 7th Forum of European Neuroscience, Amsterdam / The Netherlands, July 3-7, 2010.
73. Thermos K., Giannogonas P., Koulakis E., Kokona D., Mastrodimou N., Kiagiadaki F.,
Charalampopoulos I., Gravanis A. Immunohistochemistry and western blot methodologies to evaluate
neuroprotective agents in models of retinopathies.(invited spearker) EVER, Crete / Greece, 4412, p148, 2010.
74. Kyriaki Thermos, Despina Kokona, Ioannis Charalampopoulos, Achilleas Gravanis. DHEA
mimics NGF neuroprotective effects against retinal AMPA excitotoxicity in vivo. European Association of Vision and Eye Research (EVER) 2010. Annual Meeting. Χερσόνησος, Κρήτη, 6-9
Οκτωβρίου 2010. Η εν λόγω αναρτημένη ανακοίνωση έλαβε το πρώτο βραβείο στον τομέα
75. K. Thermos, P Giannogonas, E Koulakis, D Kokona, N Mastrodimou, F Kiagiadaki, I Charalampopoulos, A Gravanis. Immunohistochemistry and Western blot methodologies to evaluate
neuroprotective agents in models of retinopathies. Special Issue: Abstracts from the 2010 European
Association for Vision and Eye Research Conference. Acta Ophthalmologica 88, Issue Supplement s246, 2010.
76. K. Thermos, N. Mastrodimou, D. Kokona, H.A. Schmid, F. Kiagiadaki. Somatostatin analogues
as therapeutics in ischemia induced retinopathies. (invited speaker)European Neuropeptide
Conference and the European Neuropeptide Club Meeting, May 22-25 2011, Boston, Massachusets, USA
77. Despina Kokona, Ioannis Charalampopoulos, Achilles Gravanis, Kyriaki Thermos.
Dehydroepiandrosterone (DHEA) protects the retina from AMPA excitotoxicity in vivo: TrkA receptor involvement. ISN-ESN 23rd Biennal Meeting. Αθήνα, 28 Αυγούστου 2011
Kastellakis, Neuroprotective effects of the cannabinoids HU-210 against 5,7-dihydroxy tryptamine serotonergic toxicity in vivo: extensions in MDMA neurotoxicity. HSN, Athens, 2011.
Ioannis Charalampopoulos, Achille Gravanis, Kyriaki Thermos, DHEA Protects the Retina in the
STZ-model of Diabetic Retinopathy, FENS Forum 2012, Barcelona. 80. D. Kokona and K. Thermos. Synthetic cannabinoids protect the retina from AMPA-induced
excitotoxicity in vivo. 8th FENS (Federation of European Neurosciences) Forum of Neuroscience,
Barcelona, Spain, 14-18 July 2012. 81. K. Thermos, P. Iordanidou, S. Poulaki, E. Koulakis, I. Charalampopoulos, A.Gravanis
The novel neurosteroid DHEA spiro-epoxy derivative, BNN27, provides neuroprotection to the retina
when administered in drops and intraperitoneally in the STZ-model of Diabetic Retinopathy.
American Society for Neuroscience Meeting, New Orleans, LA, 2012. 82. K. Thermos, P. Iordanidou, S. Poulaki, N. Mastrodimou, E. Koulakis, I. Charalampopoulos, A.
Gravanis. The novel neurosteroid DHEA spiro-epoxy derivative, BNN27, provides neuroprotection to
the retina when administered in drops and intra-peritoneally in the STZ-model of Diabetic Retinopathy.(invited speaker) Agean Retina Meeting, Santorini, 2013.
83. E. Loyens, Csaba Z., D. De Bundel, N. Aourz, J. Coppers, S. Chai, P. Vandrheyden, K. Thermos,
Y. Michotte, P. Dournaud, I. Smolders. Inactivation of IRAP accelerates somatostatin sst2 receptor trafficking and leads to anticonvulsant effects in limbic seizure models. Symposium on
IRAP/PLAP/oxytocinase and angiotensin IV. Prato Italy, September 9-11, 2013.
84. D. Kokona, A. Zimmer and K. Thermos. Synthetic and endogenous cannabinoids protect the
retina from AMPA-induced excitotoxicity in vivo. 9th FENS (Federation of European Neuroscience Societies) Forum of Neuroscience, Milan, Italy, 05-09 July 2014.
85. K. Thermos, N. Mastrodimou, S. Lisa, R. Ibán-Arias, S. Poulaki, P. Iordanidou, D. Giannogonas,
D. Kokona, M. Kamaratou, E. Volitaki, I. Charalampopoulos, A. Gravanis. Effect of the DHEA spiro-epoxy derivatives, BNN20 and 27, in an ex vivo model of chemical ischemia and the in vivo STZ-
model of Diabetic Retinopathy: Neuroprotection via TrkA signaling. Annual meeting of the Society
for Neuroscience (SFN), Washington DC (USA), 2014 86. S. Lisa Ferrer, R. Ibán-Arias, D. Kokona, I. Charalampopoulos, A. Gravanis, K. Thermos
Effects of novel synthetic microneurotrophins in diabetic retinopathy. European Society for
87. S. Lisa , R. Ibán-Arias, N. Mastrodimou, D. Kokona, P. Iordanidou, M. Boumpouli, A. Gravanis, I. Charalampopoulos, K. Thermos. Novel microneurotrophinsprotect retinal neurons by activating the
NGF TrkA receptorin the in vivo Streptozotocin (STZ)-model of Diabetic Retinopathy and afford
88. R. Ibán Arias, S. Poulaki, S. Lisa, N. Mastrodimou, A. Gravanis, I. Charalampopoulos, K.
Thermos. The Dehydroepiandrosterone spiro-epoxy derivative, BNN27, provides neuroprotection to
31
retinal neurons in the STZ-model of Diabetic Retinopathy after eye drop administration. FENS Featured Regional Meeting (FFRM), Thessaloniki, 7-10 October, 2015
89. Ibán-Arias R, Lisa S, Kokona D, Mastrodimou N, Gravanis A, Charalampopoulos I, Thermos K.
The novel microneurotrophins BNN27 and BNN20 prevent retinal neurodegeneration in the in vivo STZ-model of Diabetic Retinopathy through NGF TrkA receptor activation. European Neuroscience
Conference by Doctoral Students (ENCODS) for doctoral students, Sesimbra, Portugal, 2015.
90. N. Mastrodimou, S. Lisa , R. Ibán-Arias, D. Kokona, I. Charalampopoulos, A. Gravanis, K.
Thermos. The novel microneurotrophin BNN27 protects retinal neurons in the in vivo STZ-model of diabetic retinopathy by activating NGF TrkA receptors, Association for Research in Vision and
Ophthalmology (ARVO), Denver (USA), 3-7 May, 2015
91. R. Ibán Arias, S. Lisa, S. Poulaki, N. Mastrodimou, D. Kokona, M. Boumpouli, A. Gravanis, I. Charalampopoulos, K. Thermos. The microneurotrophin BNN27 provides neuroprotection to retinal
neurons through NGF TrkA receptor, when it is administered either intraperitoneally or by eye-drops.
16th Congress of the Spanish Society of Neuroscience (SENC), Granada, Spain, 2015. 92. S. Lisa , R. Ibán-Arias, N. Mastrodimou, D. Kokona, P. Iordanidou, M. Boumpouli, A. Gravanis,
I. Charalampopoulos, K. Thermos. Effects of a novel synthethic neurotrophins DHEA-derivative
BNN27 in the neurodegenerative and inflammatory component of diabetic retinopathy. XXXIX
Congress of the Spanish Society of Biochemistry and Molecular Biology (SEBBM). Salamanca, Spain,2016.
93. Papadogkonaki, S. & Thermos, K. HU210 dose dependently induces the downregulation of the
CB1 cannabinoid receptor in rat retina. FENS Regional Meeting, 20-23 September 2017, Pécs, Hungary.
94. Papadogkonaki, S. & Thermos, K. Effect of subchronic and chronic administration of
endogenous and synthetic cannabinoids on CB1 cannabinoid receptor down regulation in healthy and
diseased retina. 11th FENS Forum of Neuroscience, 7-11 July 2018, Berlin, Germany. 95. Spyridakos, D. & Thermos, K. Effect of subchronic intraperitoneal administration of the
synthetic CB1/CB2 cannabinoid WIN55,212-2 on the expression of CB1 receptor in healthy and
retina and in the AMPA excitotoxicity model. 28th Meeting of the Hellenic Society for Neuroscience, 4-6 October, 2019, Heraklion, Crete, GR.
96. Spyridakos, D., Kokona, D., Papadogkonaki, S., Makriyannis, A., Malamas, M , Thermos, K. Neuroprotective effect of 2-AG and inhibitors of its metabolic enzyme
MonoAcylGlycerol Lipase (MAGL) against AMPA excitotoxicity in the retina. 28th Hellenic
Society for Neuroscience Meeting, Heraklion, October 2019. 97. Dionysopoulou,S., Wikstrom, P., Thermos, K. Investigation of the role of NADPH oxidase
inhibitors in experimental, animal models of retinopathies"28th Meeting of the Hellenic Society
for Neuroscience, 4-6 October, 2019, Heraklion, Crete, GR.
Περιλήψεις εργασιών δημοσιευμένες σε Ελληνικούς συνεδριακούς τόμους 1. Kamba, M., Hatzoglou, A., Thermos, K., Castanas, E. Direct interaction of opioids with a1-
adrenergic receptors in the human prostate cancer cell line LNCaP. Action on cell proliferation. 51η
Συνεδρία της Ελληνικής Εταιρείας Βιοχημείας και Μοριακής Βιολογίας, 1999.
2. Vasilaki, A. and Thermos, K. Elucidation of the role of somatostatin receptors in the retina: a biochemical and immunohistochemical study. 2nd Hellenic Forum on Bioactive Peptides, Patras, April
2000.
3. Θερμού, Κ. Ο ρόλος των υποδοχέων και των ενδοκυττάριων οδών στη φαρμακοδυναμική. Ετήσιο Συνέδριο Φαρμακολογίας, Αθήνα, Φεβρουάριο 2000
4. Thermos, K. The role of somatostatin in the retina. 15th Hellenic Soc Neurosci. Patras,
October 2000.
5. Vasilaki, A. and Thermos, K. Somatostatin regulates dopamine release in rat retinal explants. 15th Meeting of Hellenic Soc Neurosci. Patras, October 2000.
32
6. Mastrodimou, N., Vasilaki, A., Nifli, P. de Lecea, L., and Thermos, K. Down regulation of somatostatin receptors (sst2A and sst2B) in retinas of mice overexpressing cortistatin: An
immunohistochemical study. 15th Hellenic Soc Neurosci. Patras, October 2000.
7. Thermos, K. Functional Mapping of Somatostatin Receptors in the Retina. 19th Πανελλήνιο Συνέδριο Χημείας, Ηράκλειο. Η πολυμορφικότητα της χημείας και οι εφαρμογές της. Πρακτικά
Συνεδρίου, σελ. 540-541, 2002.
8. Λασιθιωτάκης, Κ., Παπασάββα, Δ. και Θερμού, Κ. Αλληλεπίδραση σεροτονίνης και
σωματοστατίνης στον επικλινή πυρήνα του διαφράγματος του αρουραίου. Συνέδριο Ελληνικής Εταιρείας Φοιτητών Ιατρικής Ελλάδος, Αθήνα, 2003.
9. Κουβίδη, Ε., Θερμού, Κ. Αλληλεπιδράσεις Σωματοστατίνης –Ντοπαμίνης στον
15. Thermos, Κ., Pallis, E., Vasilaki, A., Hoyer, D. , Spyraki, C. Antidepressant strategies and the putative role of somatostatin. 7th Conference Medicinal Chemistry: Drug Discovery and Design,
Patras, March 8-11, 2006.
16. Marazioti, Α., Spyraki, C., Thermos, K. Αctivation of somatostatin receptors in the globus pallidus influences rat locomotor activity. 4o Πανελλήνιο Συνέδριο Φαρμακολογίας, Πάτρα, 19-20
Μαϊου, 2006.
17. Thermos, K., Papazoglou,M., Antoniou, K., Mastrodimou, N., Panagis, G., Vlachou, S.,
Renieri, E., Nahmias, V., Menisiou, A., Gianni, M., Kondylis, M.P., Daifoti-Papadopoulou, Z., Papahatjis, D.,Spyraki,C., Pharmacological characterization of novel ligands for CB1 and CB2
18. Giannogonas P., Mastrodimou N., Charalampopoulos I., Gravanis A., Thermos K. The neurosteroid DHEA protects the retina against chemical ischemia. 6th Panhellenic Congress of
Pharmacology, Heraklion. Review of Clinical Pharmacology and Pharmacokinetics, International
Edition 24 (2), pp. 143, 2010. 19. Georgiou P.-C., Kiagiadaki F. and Thermos K. Cannabinoids protect the retinal from
chemical ischemia. HSN Annual Meeting, Athens, 2008.
20. Giannogonas P., Mastrodimou N., Charalampopoulos I., Gravanis A., Thermos K.
Neurosteroids as neuroprotective agents in a model of retinal chemical ischemia. HSN Annual Meeting, Athens, 2008
21. D. Kokona, I. Charalampopoulos, A. Gravanis, K. Thermos. DHEA and NGF protect the
retina from AMPA excitotoxicity in vivo. 6ο Πανελλήνιο Συνέδριο Φαρμακολογίας, Ελληνική Εταιρία Φαρμακολογίας, Ηράκλειο Κρήτης, 4-6 Ιουνίου 2010.
22. Despina Kokona, Ioannis Charalampopoulos, Achilleas Gravanis, Kyriaki Thermos.
DHEA mimics NGF neuroprotective effects against retinal AMPA excitotoxicity in vivo. Ερευνητική
διημερίδα της Ελληνικής Εταιρίας των Νευροεπιστημών, Αθήνα, 1-2 Οκτωβρίου 2010. Προφορική
Ανακοίνωση. Βραβείο Ελληνικής Εταιρίας Νευροεπιστημών. 23. D. Kokona and K. Thermos. Study of the neuroprotective properties of cannabinoids in
retinal ischemia. Hrakleitos II meeting, Heraklion, Crete, Greece, 4-5 December 2012. 24. D. Kokona, A. Makriyannis, A. Zimmer and K. Thermos. Endogenous cannabinoids and the
inhibitors of their metabolic enzymes protect the retina from AMPA-induced excitotoxicity in vivo. 8th
Congress of Hellenic Society for Basic and Clinical Pharmacology, Athens, Greece, 23-25 May 2014.
25. S. Papadongonaki & K. Thermos. Chronic administration of the synthetic cannabinoid HU-210 induces downregulation of the CB1 cannabinoid receptor in rat retina. 9th Congress of the
Hellenic Society for Basic and Clinical Pharmacology, Thessaloniki (Greece), 20-22 May, 2016...